Adherence to antiretroviral therapy for human immunodeficiency virus/acquired immune deficiency syndrome among drug users: a systematic review
Abstract
Aims Adherence to highly active antiretroviral therapy (HAART) is a key predictor of survival for human immunodeficiency virus (HIV)‐infected people. Suboptimal adherence among marginalized populations such as HIV‐positive drug users could be associated with clinical failure and the emergence of viral resistance.Objective To conduct a systematic review of studies assessing adherence to HAART among HIV‐positive drug users (DU) and identify factors associated with non‐adherence to HIV treatment.Data sources Seven electronic databases were searched for peer‐reviewed papers published in English, French, Spanish or Portuguese, from 1996 to 2007.Study selection and data abstraction Studies were excluded if they presented only qualitative data, were reviews themselves or assessed other populations without disaggregating data on DU. Findings on adherence were extracted and summarized.Data synthesis Forty‐one studies were considered, which studied a total of 15 194 patients, the majority of whom were HIV‐positive DU (n = 11 628, 76.5%). Twenty‐two studies assessed adherence using patient self‐reports, eight used pharmacy records, three used electronic monitoring [i.e. Medication Event Monitoring Systems (MEMS) caps], six studies used a combination of patient self‐report, clinical data and MEMS‐caps, and two analyzed secondary data. Overall, active substance use was associated with poor adherence, as well as depression and low social support. Higher adherence was found in patents receiving care in structured settings (e.g. directly observed therapy) and/or drug addiction treatment (especially substitution therapy).Conclusion While lower than other populations—especially among users of stimulants, incarcerated DU and patients with psychiatric comorbidities—adherence to HAART among HIV‐positive DU can be achieved. Better adherence was identified among those engaged in comprehensive services providing HIV and addiction treatment with psychosocial support.Keywords
This publication has 65 references indexed in Scilit:
- Antiretroviral treatment for injecting drug users in developing and transitional countries 1 year before the end of the ‘Treating 3 million by 2005. Making it happen. The WHO strategy’ (‘3by5’)*Addiction, 2006
- Drug Use and Medication Adherence among HIV-1 Infected IndividualsAIDS and Behavior, 2006
- Substance Abuse and Medication Adherence Among HIV-Positive Women with Histories of Child Sexual AbuseAIDS and Behavior, 2006
- Pharmacotherapy and other treatments for cocaine abuse and dependenceCurrent Opinion in Psychiatry, 2005
- Integration of Motivational Interviewing and Cognitive Behavioral Therapy to Improve HIV Medication Adherence and Reduce Substance Use Among HIV-Positive Men and Women: Results of a Pilot ProjectAIDS Patient Care and STDs, 2005
- Mortality in HIV‐Seropositive versus ‐Seronegative Persons in the Era of Highly Active Antiretroviral Therapy: Implications for When to Initiate TherapyThe Journal of Infectious Diseases, 2004
- Relationship Between Routinization of Daily Behaviors and Medication Adherence in HIV-Positive Drug UsersAIDS Patient Care and STDs, 2004
- Placebo Practice Trials: The Best Predictor of Adherence Readiness for HAART Among Drug Users?HIV Research & Clinical Practice, 2003
- Is there a baseline CD4 cell count that precludes a survival response to modern antiretroviral therapy?AIDS, 2003
- Routes of drug administration, differential affiliation, and lifestyle stability among cocaine and opiate usersJournal of Substance Abuse, 2001